Updated German S3 Guideline Recommends First-Trimester Diabetes Risk Screening and Metformin as Insulin Alternative for Gestational Diabetes
Metformin can now be offered to pregnant women with gestational diabetes who need drug therapy, as an alternative to insulin, under a revised German clinical guideline published on November 19.
The updated S3 guideline also pushes diabetes risk assessment to the first prenatal visit.
- Germany’s gynecology and diabetes societies have jointly revised the national S3 guideline on gestational diabetes.
- Risk factors should now be checked at the first-trimester visit, with targeted glucose testing when they are present.
- Metformin is newly named as an insulin alternative, and birth planning rules set out when labor induction should be offered.
The German Society for Gynecology and Obstetrics (DGGG) and the German Diabetes Society (DDG) revised the guideline, “Gestational Diabetes Mellitus (GDM): Diagnosis, Therapy and Follow-Up Care,” under joint leadership, according to Monitor Versorgungsforschung. Its stated aims are to standardize prevention, screening, diagnosis, treatment and follow-up across outpatient and inpatient settings, and to strengthen cooperation between specialties and levels of care.
Under current German maternity directives, routine screening happens between weeks 24 and 28 of pregnancy. Because an existing metabolic disorder is often only caught at that standard screen, risk factors should now be recorded at the first presentation in the first trimester, with a targeted examination of glucose metabolism when they are found.
Early screening has limits, the societies caution. For an “early GDM” detected in the first trimester, the recommendation on treatment is qualified, because the benefit of early treatment has not been clearly established. Early screening is not yet part of the maternity directives; an application to the Federal Joint Committee (G-BA) is in preparation, according to the professional societies.
Women planning a pregnancy who have overweight or obesity should be advised to reduce weight through a healthy lifestyle before conception, and women in early pregnancy should receive counseling on physical activity and nutrition, the guideline says.
“Among the new recommendations is also that women with GDM and overweight or obesity should be encouraged to aim for the lowest possible weight gain, and that pregnant women with GDM who require medication can also be offered metformin as an alternative to insulin,” said PD Dr. med. Katharina Laubner, guideline coordinator for the DDG, University Medical Center Freiburg.
Blood sugar self-monitoring should be limited to the minimum needed for treatment decisions, the guideline states.
Birth planning and where to deliver
Gestational diabetes raises the risk of babies born large for gestational age (LGA), which carries risks of shoulder dystocia and cesarean delivery, as well as the risk of preeclampsia. The coordinators point to clinical practice as evidence the current timing falls short.
“We are increasingly seeing pregnant women whose diagnosis is only made at the mandatory screening for gestational diabetes at 24 to 28 weeks of gestation, by which time the baby has already developed excessive, diabetes-typical growth,” said Prof. Dr. med. Ute Schäfer-Graf, guideline coordinator for the DGGG, St. Joseph Hospital Berlin.
On delivery timing, the guideline recommends offering induction of labor from 39+0 weeks of gestation when the estimated fetal weight is above the 95th percentile. From an estimated weight above 4,250 grams, women should be informed about the risk of shoulder dystocia. Because of the risk of neonatal hypoglycemia, delivery should take place in a facility with continuous pediatric presence.
After the birth: screening, depression, breastfeeding
Follow-up care now begins before delivery. All women with GDM should be invited during pregnancy to a postpartum diabetes screening, ideally between weeks 6 and 12 after birth. After drug treatment, persisting diabetic metabolism should be ruled out before hospital discharge.
The guideline adds screening for peripartum depression and a recommendation of six months of exclusive breastfeeding. Long term, the societies note, mothers face elevated risks of diabetes, metabolic syndrome, recurrent gestational diabetes and cardiovascular disease, while their children carry an increased risk of overweight.
The full text is available in the AWMF register as the S3 guideline on gestational diabetes. The DDG, which has more than 9,300 members and has worked in medical training and guideline development since 1964, and the DGGG both describe the update as a step toward uniform care.
Women facing a new GDM diagnosis can seek specialists in obstetric diabetology and certified diabetes treatment facilities the DDG certifies, and after delivery, a primary care physician or diabetologist can schedule the recommended postpartum glucose screening.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.